HIV/AIDS

Efficient Treatment with Simple Methods
By Kwame Ingemar Ljungqvist submitted to the website in february 2007

In Africa some succesful trials are ongoing in an attempt to use food additives and colloidal silver to treat Aids. Harald Foster and the Swede Anders Sultan are the driving forces behind two projects.
Here is given a brief up-date.

In the Journal of Third Millenium Science we have not written that much about medication against HIV-infection. The best documented and also efficinet work in this aspect emanate from the research and clinical succesful experience made by the late ugandian-british professor Charles Ssali, who developed his own formula; Mariandina - a pill that contained traditional herbs, minerals, vitamins and amino-acids.
The industrially produced stop-medications are all synthetic biomolecules who interact with the viral life-cycle and interferes with the viral production, which give the patient a certain time benfit. But these medications are considered foreign by the body itself and therefore they overload the body´s main cleansing organs: liver and kidneys. The extra load of the body leads to devastaing results for these organs. If the patient doesn´t die from Aids the powerful side-effects from this medication gives lifethreatening damage to organs,

Two modifications of the Ssali medications
This millenium have been met by two modifications of the Ssali formula. Harald Foster is the leading proponent of one. In this case you support your body with the essential substances which are in extra high need during an HIV-infection.. The viral metabolism seem to interfere with these substances and empty them at a higher rate than normally. The substances are the three amino-acids cysteine, tryptophane and glutamine and the mineral selenium.
The other variety of treatment is the one outgoing from a mode to hamper the virus by using an ion of silver to attach to the viral envelope, thereby inhibiting the viral own functions. Colloidal silver is before known to be an useful agent against virus, bacteria and fungi. Many patient anecdotal stories, especially from the US, tells us that colloidal silver also is a strong agent against HIV.

Glutation-peroxidase and HIV
One of the most powerful enzymes produced by our cells to destroy invaders and reestablish a competent immune system is the enzyme glutathion-peroxidase. It is also one of the enzymes that need one atom of the element selenium in its structure, probably bound to the amino-acid seleno-cysteine. Earlier findings state that the rate of selenium is guiding for the outcome of the HIV-infection. Low rates of selenium indicate that the onset of full-blown AIDS is to be expected, whereas high titres of selenium gives a far better prognoses. You may in the latter case be the carrier of the HIV without no serious clinical symptoms.
The same has been noticed for the three amino-acids which all are considerable parts of the glutathione-peroxidase: Glutamine, tryptophane and cysteine. Harald Foster claims that HIV itself codes for this enzyme which makes it to a competitor with the body in the demand for these amino-acids in order to synthesize glutathione-peroxidase. These may reduce the amount of availabe building blocks and when this happened the titres of the containing amino-acids as well as that of glutathione-peroxidase may be detrimantely reduced.
During the early 20th century the disease pellagra was uprooted in the US southern states by adding vitamin B2 to the food. In the corresponding way it would be probable to booster the immune-system in HIV-carriers by adding these essential building blocks as food supplements.
Harald Foster has also noticed that few develop AIDS in the west-african country Senegal, which may have its explanation that the fertile soil in Senegal has the highest titres of selenium that is known.

Clinical trials in Africa
Harald Foster is involved in four clinical trials i four african countries. In South Africa capsules which contain a mixture of the four substances are given to diseased aids-patients at a hospital. After only a few weeks astonishing results were recorded. The patients got rid of their nightly sweatings, their diarrhoea and could leave the hospital. The trial started in 2004 anf follow-up studies are ongoing at an out-ward health clinic in South Africa.
The first preliminary results show that five out of six patients have achieved a considerable improvement in their health. That not all do, depends upon the severe diarrhoea in some patients that hampers the absorption of the capsule content since it is taken orally.
Another smaller trial in Kenya showed similar result. At present two greater clinical trials are ongoing in Uganda and Zambia. In the ugandian trial preliminary reports show that 77% out of 40 patients has improved their health situation.

Colloidal silver
Anders Sultan and his company Ion.Silver in Löddeköpinge, Sweden look forward to many areas of application for colloidal silver for HIV-patients. The silver-ionized water can e.g. be supplied to the whole population through the drinking water or through the food supply. Or it can be given exclusively to HIV-positive people. There is also a good chance in combining the two methods described in this article.
Earlier trials and reports from using colloidal silver in HIV-infection goes back to 1992, when it was confirmed how efficiently a silver-ion bound to the envelope of the virus, from where the ion severly interrupts the virus-own enzymatic functions.
It is also known that silver, even in high doses are relatively free from side-effects in healthy human cells. The almost only recorded side-effect is a noticeable miscolouring of the skin with a blueish appearance. The Swedish Board for Food Administartion (Livsmedelsverket) has therefore approved the use of silver, not for its virocidal or bacterocidal properties, but as a colour pigment to cheer up the outlook of candy and pastries. (!) This approval has made it possible to sell ionized silver as a food supplement..
Today the information about silver as an excellent virucidal agent is spread but in the framework of the law, only as a food additive. Any costly doubble-blinded, placebo-controlled, randomized clinical trial can´t be achieved, because these small pioneering firms don´t have the finacial means to do so. Moreover it is hardly possible to get that investment to pay back, because it would be almost impossible to patent the simple procedure used to make colloidal silver in nanometer-sized particles outgoing from pure raw, solid silver. In the Swedish case they buy their silver from Norwegian silvermines. Since colloidal also is active against a number of other infections it can be used at a broad range where an infectious agent is involved. Concerning Aids two trials have started in Kenya and Zambia. The reports from these trials are similar promising as those of Harald Foster.

Pilot project with colloidal silver against HIV/AIDS in Kenya
Anders Sultan is obviously conscious that colloidal silver is considered a threat to the pharmaceutical industry and their patentable engineered HIV-medications. Therefore, he says, it is of outmost importance to build up networks of doctors, nurses and patients where all are involved in the treatment process.
During autumn 2005 and spring 2006 a Swedish financed project has been taken place in Kenya with treatment by colloidal silver. More than 30 HIV-infected women and their children have been given colloidal silver in the waterdilution of 10 ppm to drink. The administered dose has been a half teaspoon (2,5 ml) a day the first week. This has been increased gradually the f.f. weeks to achieve the amount of a full spoon (15 ml) a day after a couple of weeks. The gradual increase has been done to overcome the first signs of deterioration that is often noticed in these patients. The results has often been fast and astonishing. The women at the beginning very clearly got abortion symptoms of itches, sweating, rushes, hunger, thirst, headache and fatigue. After a few weeks these symptoms faded away and a stedy recovery could start. After a month or two all symptoms were gone and the women felt healthy and strong. After renewed tests a couple of months afterwards (both HIV and CD4-tests) for four women - two were now HIV-negative and all showed remarkably higher CD4-counts. You must always keep in mind that the HIV-test doesn´t test for the virus directly but for antibodies against the virus. These antibodies can be present when other infections are present, so these antibody-test are not too specific. Also the presence of antibodies can sustain in the body up to 18 months after the agent is gone, depending on the average lifelength of the antibodies in the blood plasma. Taken this information into consideration, the above mentioned result with two women that converted into sero-negativity after only a couple of months is even more promising. Combined with the result of increased CD4 counts this result must be of greatest value to be followed by more studies. The CD4-counting is a measurement of how many competent T4-helpercells that are available in the immune system.
The females were at the beginning of the trial at a CD4 cell count between 9-100. After a couple of months it had increased to 700 - 900. The considered amount in healthy persons are estimated to 500 -1600. If you are below 200 and HIV-infected it is synonomous with AIDS.

Malaria and children diarrhoea
As a complementary observation in these AIDS-studies also malaria and diarrhoea were observed in children and the impact of colloidal silver om these ailments. The outcome of these observations also follow a pattern that was observed by an American company trading with colloidal silver. Their study shows a person can be free from their malaria infection within five to ten days with the support of colloidal silver. Then you are talking about a cure, because the Plasmodium, the malaria agent, is fully depleted from the body. In children diarrhoea, the time relapse vary from a few hours to a couple of days, before the symptom disappears. Children diarrhoea is a big killer in Africa with several thousand victims every day.

Preliminary results from Zambia
Even preliminary results from a pilot study, using colloidal silver, performed in Zambia has been reported. In this study the impact on malaria, children diarrhoea and stomach diseases has been observed. Colloidal silver with the titre of 10 ppm and also a water cleansing system with silver titres of 50 ppb (Parts per billion) has been used. Both methods have a good impact on fungi, bacteria, virus and plasmodium. People using the silver treated water have got rid of as well chronical as acute life-threatening diseases.The quantity used is equivalent to an intake of 15 cl colloidal silver of the titre 10 ppm, three times a day. It is thus possible to cure a human being from life threatening diseases as AIDS or malaria for about ten dollars. The coordinators of the pilot study have asked for contribution from other aid organizations, but they have all denied help. Also requests from Swedish organizations have been unanswered.

Possibly it would be useful to combine the food supplement treatment of Harald Foster with colloidal silver. The addition of essential amino-acids and selenium support the body´s immune sytem whereas the mode of action of colloidal silver neutralizes the virus.
Is this the succesful path to walk to release the world from the dreaded disease AIDS?
To get rid of the agent HIV is a further more patient task.


References:

Foster Harold D. How HIV-1 causes AIDS:implications for prevention and treatment- Medical Hypotheses 2004;62:549-553

Nyberg-Svensson Birgit. Selen - en atom som samverkar med syre till liv. 2000-Talets Vetenskap 2002;2:6-9

Ssali Charles. Värdet av antioxidanter och mikronäringsämnen i behandlingen av aids. 2000-Talets Vetenskap 1996;4:

Ssali Charles. AIDS-patienter som fått Mariandina under lång tid. 2000-Talets Vetenskap 1998;1:7-9

Sultan Anders. Kolloidalt silver. 2000-Talets Vetenskap 2003;2:3-9 See also http://www.ion-silver.com

Ljungqvist Ingemar. Behandling mot HIV - för att förhindra Aids. Kap 14 in Aids Tabu pages 209-240 Carlssons Bokförlag, Stockholm 1992

Foster Harold D. What Really causes AIDS, Trafford Press, Victoria Canada, 2002. Boken finns också som pdf-fil på http://www.hdfoster.com